pillbase.ru

Sufentanil Citrate

Active substance: sufentanil

INJECTION, SOLUTION · SUFENTANIL CITRATE 50 ug/mL

United StatesActive

Marketing holder: Hospira, Inc.

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
EU 3
  • Dzuveo
    sufentanil citrate
    EMEA/H/C/004335
    Laboratoire Aguettant
  • KemSu
    ketamine hydrochloride, sufentanil citrate
    EMEA/H/C/006395
    Proveca Pharma Limited
  • Zalviso
    sufentanil
    EMEA/H/C/002784
    FGK Representative Service GmbH
Import and control

Control by country

  • United StatescontrolledSchedule: CII

    Source: openFDA NDC · record 01a12092-93c0-796a-9756-e5decadad2ae;count=1 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
0409-3382
Registration status
Active
Dispensing
Prescription only
Control marker
CII
Route
EPIDURAL, INTRAVENOUS
Sources
  • product · openFDA NDC · 0409-3382 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 0409-3382 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 0409-3382 · Verified 2026-10-09 · open in source